| Cardiothyreosis clinical data | All patients (n = 150) | Cardiothyreosis inaugural (n = 70) | Age > 50 years (n = 49) |
| Palpitation | 97.3% | 98% | 100% |
| Tachycardia | 64.6% | 64.7% | 52% |
| Heart dyspnea stages I and II | 21.3% | 24.2% | 22.4% |
| Heart dyspnea stage III | 64.6% | 58.5% | 63.2% |
| Heart dyspnea stage IV | 14% | 17.1% | 12.2% |
| Cardiovascular excitability | 24% | 22.8% | 20.4% |
| Orthopnea | 13.3% | 17.1% | 12.2% |
| Acute pulmonary edema | 3.3% | 4.2% | 4% |
| Edema of lower limbs | 66% | 61.4% | 63.2% |
| jugular vein high pressure | 70.6% | 69% | 73.4% |
| Hepatomegaly | 11.3% | 11.4% | 12.2% |
| Ascites | 2.6% | 4.2% | 0% |
| Pleural effusion | 0.6% | 0% | 2% |
| Cardiac rhythm disorders | 42.6% | 41.4% | 38.7% |
| Gallop | 8% | 7.1% | 4% |
| Heart Murmur | 22% | 24.2% | 12.2% |